Radiographic Evaluation of The Labial Bone Dimensional Changes After Immediate Implant

September 4, 2022 updated by: Nesma Mohamed Fouad Shemais, Cairo University

Evaluation of Horizontal and Vertical Labial Bone Dimensional Changes After Flapless Immediate Implant Placement With and Without Bone Grafting: A 1-year Cone-beam Computed Tomography Randomized Clinical Trial.

For the dimension of the peri-implant buccal gap, a controversy is present whether complete bone formation labial to the implant. Therefore, leaving the blood clot in the large socket around implants without augmentation is questionable to result in complete bone fill and would not affect the buccal contour collapse. The aim of this clinical trial was to evaluate the labial bone dimensional changes after immediate implant placement in the esthetic zone with & without bone grafting inside the socket by using CBCT superimposition (Fusion) scans.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maadi
      • Cairo, Maadi, Egypt, 11728
        • International Dental Continuing Education
    • Manial
      • Cairo, Manial, Egypt, 35855
        • Faculty of Dentistry, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

inclusion criteria:

  1. adult (>20 years) with non-restorable maxillary teeth in the esthetic zone,
  2. thick gingival phenotype,
  3. intact but thin labial plate of bone (≤1mm)
  4. intact palatal bone extending at least 6mm apically,
  5. sufficient apical bone to attain implant primary stability (a minimum of 35 Ncm insertion torque)
  6. labio-palatal socket dimension measured from the CBCT axial cut at mid-crestal part ≥5mm.
  7. patients agreed to sign a written informed consent.

Exclusion criteria:

  1. smokers,
  2. pregnant women,
  3. patients with systemic disease,
  4. patients with parafunctional habits such as bruxism or clenching,
  5. infected socket,
  6. periapical pathosis
  7. history of radiotherapy or chemotherapy within the past 2 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: immediate implant placement without bone grafting
After atraumatic extraction of the non-restorable tooth using periotome and luxators, osteotomy site preparation will be done 3-5mm into the bone apical to the socket according to the manufacturer's instructions. Patients will receive an immediate post-extraction implant without any grafting material in the socket between the residual labial bone and implant surface.
After atraumatic extraction of the non-restorable tooth using periotome and luxators, osteotomy site preparation will be done & patients will receive an immediate post-extraction implant without any grafting material in the socket between the residual labial bone and implant surface. After implant insertion, the labial bone dimensions of the buccal peri-implant defect will be measured using Automated Voxel Superimposition Method of CBCT scans. All the patients in this study had two scans; primary (preoperative) scan and secondary (Postoperative) scan, with standardization of the exposure parameters. All datafrom CBCT examinations were acquired in a DICOM format which were imported to OnDemand3D ®App software (Cybermed, Seoul, Korea). superimposition of DICOM sets of each patient using Fusion module of Ondemand 3D App software was done.
Active Comparator: immediate implant placement with bone grafting
After atraumatic extraction of the non-restorable tooth using periotome and luxators, osteotomy site preparation will be done 3-5mm into the bone apical to the socket according to the manufacturer's instructions. Patients will receive an immediate post-extraction implant with placing bovine bone graft (Bio-oss) in the socket between the residual labial bone and implant surface.
After atraumatic extraction of the non-restorable tooth using periotome and luxators, osteotomy site preparation will be done and patients will receive an immediate post-extraction implant with placing bovine bone graft (Bio-oss) in the socket between the residual labial bone and implant surface. After implant insertion, the labial bone dimensions of the buccal peri-implant defect will be measured using Automated Voxel Superimposition Method of CBCT scans. All the patients in this study had two scans; primary (preoperative) scan and secondary (Postoperative) scan, with standardization of the exposure parameters. All datafrom CBCT examinations were acquired in a DICOM format which were imported to OnDemand3D ®App software (Cybermed, Seoul, Korea). In order to ensure standardization and reproducibility of the CBCT cross sectional images used in this study, superimposition of DICOM sets of each patient using Fusion module of Ondemand 3D App software was done.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Amount of bone labial to the implant
Time Frame: 1 year
CBCT superimposition (fusion scans)
1 year
Horizontal labio-palatal bone width
Time Frame: 1 year
CBCT superimposition (fusion scans)
1 year
horizontal labio-palatal bone collapse
Time Frame: 1 year
CBCT superimposition (fusion scans)
1 year
vertical bone dimensional changes
Time Frame: 1 year
CBCT superimposition (fusion scans)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gingival index
Time Frame: 1 year
bleeding on probing around customized healing abutments placed on the immediate implants
1 year
Implant failure
Time Frame: 1 year
The following are the criteria of the implant success: the absence of mobility, the absence of acute or chronic peri-implant infection, the absence of radiolucency around the implant, without pocket probing depth (PPD) ≧ 5 mm, and without vertical bone loss ≧ 1.5 mm in the first year. The cases will be defined as failure if it can't reach any one of the success criteria.
1 year
Plaque Index
Time Frame: 1 year
Plaque index
1 year
Postoperative Pain
Time Frame: 1 day, 3 days, 7 days
VAS
1 day, 3 days, 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Noha A Ghallab, PhD, Professor of Oral Medicine & Periodontology
  • Study Director: Ahmed I Abou- El-Fettouh, MSc, Misr International University
  • Principal Investigator: Abdelrahman Zohny, BDs, Misr International University
  • Principal Investigator: Nael M Adel, BDs, Misr International University
  • Study Chair: Khaled Abdelghaffar, PhD, Professor of Periodontology, Ain Shams University
  • Principal Investigator: Mariam S Abdelmalak, BDs, Misr International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Actual)

April 1, 2022

Study Completion (Actual)

April 29, 2022

Study Registration Dates

First Submitted

April 30, 2022

First Submitted That Met QC Criteria

April 30, 2022

First Posted (Actual)

May 4, 2022

Study Record Updates

Last Update Posted (Actual)

September 8, 2022

Last Update Submitted That Met QC Criteria

September 4, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • IDCE.N1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Immediate Implants

Clinical Trials on immediate implant placement without bone grafting

3
Subscribe